NCT01402882View on ClinicalTrials.gov

Clinical Randomisation of an Antifibrinolytic in Significant Head Injury

PHASE3CompletedINTERVENTIONAL
Enrollment

12,737

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions
Traumatic Brain Injury
Interventions
DRUG

Tranexamic Acid

2 grams (1 gram over 10 minutes and 1 gram over 8 hours)

Trial Locations (1)

Unknown

High Technology Medical Center, University Clinic, Tbilisi

All Listed Sponsors
lead

London School of Hygiene and Tropical Medicine

OTHER

NCT01402882 - Clinical Randomisation of an Antifibrinolytic in Significant Head Injury | Biotech Hunter | Biotech Hunter